PortfoliosLab logo
EW vs. MTD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between EW and MTD is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

EW vs. MTD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Edwards Lifesciences Corporation (EW) and Mettler-Toledo International Inc. (MTD). The values are adjusted to include any dividend payments, if applicable.

2,000.00%3,000.00%4,000.00%5,000.00%6,000.00%December2025FebruaryMarchAprilMay
5,348.73%
2,521.56%
EW
MTD

Key characteristics

Sharpe Ratio

EW:

-0.29

MTD:

-0.41

Sortino Ratio

EW:

-0.08

MTD:

-0.40

Omega Ratio

EW:

0.98

MTD:

0.95

Calmar Ratio

EW:

-0.22

MTD:

-0.35

Martin Ratio

EW:

-0.52

MTD:

-0.94

Ulcer Index

EW:

22.74%

MTD:

15.90%

Daily Std Dev

EW:

41.36%

MTD:

36.47%

Max Drawdown

EW:

-54.32%

MTD:

-61.43%

Current Drawdown

EW:

-42.67%

MTD:

-37.54%

Fundamentals

Market Cap

EW:

$44.31B

MTD:

$22.68B

EPS

EW:

$2.38

MTD:

$40.04

PE Ratio

EW:

31.79

MTD:

27.25

PEG Ratio

EW:

4.22

MTD:

3.69

PS Ratio

EW:

7.97

MTD:

5.99

PB Ratio

EW:

4.43

MTD:

3.98K

Total Revenue (TTM)

EW:

$5.54B

MTD:

$3.83B

Gross Profit (TTM)

EW:

$4.39B

MTD:

$2.29B

EBITDA (TTM)

EW:

$1.77B

MTD:

$1.20B

Returns By Period

In the year-to-date period, EW achieves a 1.20% return, which is significantly higher than MTD's -13.10% return. Over the past 10 years, EW has outperformed MTD with an annualized return of 13.57%, while MTD has yielded a comparatively lower 12.58% annualized return.


EW

YTD

1.20%

1M

8.02%

6M

12.34%

1Y

-11.95%

5Y*

0.61%

10Y*

13.57%

MTD

YTD

-13.10%

1M

3.98%

6M

-23.27%

1Y

-14.98%

5Y*

7.76%

10Y*

12.58%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

EW vs. MTD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EW
The Risk-Adjusted Performance Rank of EW is 3636
Overall Rank
The Sharpe Ratio Rank of EW is 3535
Sharpe Ratio Rank
The Sortino Ratio Rank of EW is 3434
Sortino Ratio Rank
The Omega Ratio Rank of EW is 3232
Omega Ratio Rank
The Calmar Ratio Rank of EW is 3737
Calmar Ratio Rank
The Martin Ratio Rank of EW is 4040
Martin Ratio Rank

MTD
The Risk-Adjusted Performance Rank of MTD is 2828
Overall Rank
The Sharpe Ratio Rank of MTD is 2828
Sharpe Ratio Rank
The Sortino Ratio Rank of MTD is 2525
Sortino Ratio Rank
The Omega Ratio Rank of MTD is 2626
Omega Ratio Rank
The Calmar Ratio Rank of MTD is 2929
Calmar Ratio Rank
The Martin Ratio Rank of MTD is 2929
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

EW vs. MTD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and Mettler-Toledo International Inc. (MTD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current EW Sharpe Ratio is -0.29, which is comparable to the MTD Sharpe Ratio of -0.41. The chart below compares the historical Sharpe Ratios of EW and MTD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00December2025FebruaryMarchAprilMay
-0.29
-0.41
EW
MTD

Dividends

EW vs. MTD - Dividend Comparison

Neither EW nor MTD has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

EW vs. MTD - Drawdown Comparison

The maximum EW drawdown since its inception was -54.32%, smaller than the maximum MTD drawdown of -61.43%. Use the drawdown chart below to compare losses from any high point for EW and MTD. For additional features, visit the drawdowns tool.


-50.00%-45.00%-40.00%-35.00%-30.00%-25.00%-20.00%-15.00%December2025FebruaryMarchAprilMay
-42.67%
-37.54%
EW
MTD

Volatility

EW vs. MTD - Volatility Comparison

The current volatility for Edwards Lifesciences Corporation (EW) is 9.98%, while Mettler-Toledo International Inc. (MTD) has a volatility of 17.21%. This indicates that EW experiences smaller price fluctuations and is considered to be less risky than MTD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%December2025FebruaryMarchAprilMay
9.98%
17.21%
EW
MTD

Financials

EW vs. MTD - Financials Comparison

This section allows you to compare key financial metrics between Edwards Lifesciences Corporation and Mettler-Toledo International Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


600.00M800.00M1.00B1.20B1.40B1.60B20212022202320242025
1.41B
883.74M
(EW) Total Revenue
(MTD) Total Revenue
Values in USD except per share items

EW vs. MTD - Profitability Comparison

The chart below illustrates the profitability comparison between Edwards Lifesciences Corporation and Mettler-Toledo International Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%20212022202320242025
78.8%
59.5%
(EW) Gross Margin
(MTD) Gross Margin
EW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Edwards Lifesciences Corporation reported a gross profit of 1.11B and revenue of 1.41B. Therefore, the gross margin over that period was 78.8%.

MTD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Mettler-Toledo International Inc. reported a gross profit of 525.88M and revenue of 883.74M. Therefore, the gross margin over that period was 59.5%.

EW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Edwards Lifesciences Corporation reported an operating income of 409.90M and revenue of 1.41B, resulting in an operating margin of 29.0%.

MTD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Mettler-Toledo International Inc. reported an operating income of 236.73M and revenue of 883.74M, resulting in an operating margin of 26.8%.

EW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Edwards Lifesciences Corporation reported a net income of 358.00M and revenue of 1.41B, resulting in a net margin of 25.3%.

MTD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Mettler-Toledo International Inc. reported a net income of 163.59M and revenue of 883.74M, resulting in a net margin of 18.5%.